Sclerostin and DKK1 in postmenopausal osteoporosis treated with denosumab
Abstract The bone mass benefits of antiresorbers in postmenopausal osteoporosis are limited by the rapid coupling of decreasing bone resorption with bone formation. Wnt signaling is involved in this coupling process during treatment with bisphosphonates, whereas its role during treatment with the an...
Gardado en:
Main Authors: | , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | inglés |
Publicado: |
2012
|
Acceso en liña: | https://doi.org/10.1002/jbmr.1681 |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|